Sociodemographic and behavioral factors associated with controlled hypertension after 9 years of observation of a PURE Poland cohort study.
Poland
blood pressure-prevention and control
cohort
hypertension
hypertension prevention and control
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
02
2023
accepted:
28
03
2023
medline:
9
5
2023
pubmed:
8
5
2023
entrez:
8
5
2023
Statut:
epublish
Résumé
Despite some improvement in awareness and treatment of hypertension, blood pressure control is still below expectations in Poland. The aim of the study was to analyze the secular trend of hypertension prevalence in the PURE Poland cohort study over 9 years of observation and to analyze factors associated with controlled HT. The study group consisted of 1,598 participants enrolled in a Prospective Urban and Rural Epidemiological Study (PURE), who participated both in baseline (2007-2010) and 9-year follow-up (2016-2019). Hypertension was ascertained on the basis of (1) self-reported hypertension previously diagnosed by the physician, (2) self-reported anti-hypertensive medication, and/or (3) an average of two blood pressure measurements ≥140 mmHg systolic BP and/or ≥90 mmHg diastolic BP. The prevalence of hypertension increased from 69.4% at baseline to 85.9% at 9-year follow-up. The chance of HT was 8.6-fold higher in the oldest vs. the youngest age group [OR 8.55; CI 4.47-16.1]. Male sex increased the chance for hypertension over 3-fold [OR 3.23; CI 2.26-4.73]. Obesity, according to BMI, increased the chance of HT 8-fold [OR 8.01; CI 5.20-12.8] in comparison with normal body weight. Male sex decreased the chance of controlled HT after 9 years [OR 0.68; CI 0.50-0.92]. There was no statistically significant association between controlled HT and age or place of residence. Higher and secondary education increased the chance of controlled HT over 2-fold in comparison with primary education [OR 2.35; CI 1.27-4.34, OR 2.34; CI 1.33-4.11]. Obesity significantly decreased the chance of controlled HT after 9 years in comparison with normal body weight [OR 0.54; CI 0.35-0.83]. Factors significantly increasing the chance for controlled hypertension after 9 years were female sex, secondary and tertiary education, normal body weight, and avoiding alcohol drinking. Changes in lifestyle, with special emphasis on maintaining normal body weight, should be the basis of prevention and control of HT.
Identifiants
pubmed: 37151593
doi: 10.3389/fpubh.2023.1167515
pmc: PMC10160614
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1167515Informations de copyright
Copyright © 2023 Zatońska, Basiak-Rasała, Połtyn-Zaradna, Gaweł-Dąbrowska, Wołyniec, Karczewski and Szuba.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Ann Agric Environ Med. 2011;18(2):260-4
pubmed: 22216793
Blood Press. 2011 Jun;20(3):145-52
pubmed: 21133826
PLoS Med. 2011 Jun;8(6):e1000440
pubmed: 21695075
J Am Heart Assoc. 2015 Sep 21;4(9):e002275
pubmed: 26391135
J Hum Hypertens. 2004 Aug;18(8):557-62
pubmed: 15129232
J Am Heart Assoc. 2018 Jun 27;7(13):
pubmed: 29950485
Nat Rev Cardiol. 2021 Nov;18(11):785-802
pubmed: 34050340
Kardiol Pol. 2018;76(2):353-361
pubmed: 29131289
Lancet. 2019 Aug 24;394(10199):639-651
pubmed: 31327564
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100
pubmed: 31043891
Kardiol Pol. 2016;74(7):681-90
pubmed: 26620680
Pol Arch Med Wewn. 2015;125(4):249-59
pubmed: 25764004
Cardiol J. 2018;25(3):333-344
pubmed: 29671863
JAMA Cardiol. 2019 May 1;4(5):455-459
pubmed: 30916719
J Hypertens. 2021 Apr 1;39(4):740-748
pubmed: 33186320
Circ Res. 2015 Mar 13;116(6):991-1006
pubmed: 25767285
JAMA. 2020 Sep 22;324(12):1190-1200
pubmed: 32902588
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
Am Heart J. 2009 Jul;158(1):1-7.e1
pubmed: 19540385
JAMA Cardiol. 2020 Mar 1;5(3):19-26
pubmed: 31940010
BMC Public Health. 2022 May 4;22(1):883
pubmed: 35508994
Hypertension. 2022 Sep;79(9):1971-1980
pubmed: 35616029
JAMA. 2020 Sep 22;324(12):1208-1210
pubmed: 32857101
Lancet. 2018 Aug 11;392(10146):496-506
pubmed: 30129465
J Am Heart Assoc. 2020 Sep 15;9(18):e017334
pubmed: 32900264
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Int J Equity Health. 2016 Dec 8;15(1):199
pubmed: 27931255
J Clin Med. 2021 Nov 30;10(23):
pubmed: 34884357
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875
JAMA. 2021 Mar 16;325(11):1108-1109
pubmed: 33724316